JJDC
holder of more than 5% of our outstanding common stock at the time of the IPO
$ 5,000,000
Purchased shares of Class A common stock in our IPO at $16.00 per share (312,500 shares).
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased shares of Class A common stock in our IPO at $16.00 per share (312,500 shares).
Purchased shares of Class A common stock in our IPO at $16.00 per share (625,000 shares).
Purchased shares of Class A common stock in our IPO at $16.00 per share (125,000 shares).
Purchased shares of Class A common stock in our IPO at $16.00 per share (1,500,000 shares).
Purchased shares of Class A common stock in our IPO at $16.00 per share (900,000 shares).
Amended and restated Investors' Rights Agreement granting certain holders registration rights.
Exclusive worldwide license of PIPE-307 granted to J&J; we received an upfront payment.
Employed as an Associate Director; compensation comparable to similarly situated employees and approved by the compensation committee.
Legal consulting agreement with monthly retainer, later increased; terminated June 3, 2024.
Strategic, scientific and clinical consulting advisor agreement with monthly retainer, reduced later; option for 5,000 shares granted June 2024; terminated March 14, 2025.
Loading...
